Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...

On March 3, 2025, the U.S. Department of Health and Human Services (HHS) published a policy statement rescinding a decades-old ...

Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...

A federal pharmaceutical testing facility in St. Louis will remain open, despite appearing on DOGE’s list of scheduled office ...

The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...

Health experts have slammed the FDA as 'corrupt' and 'in bed with Big Pharma' after its former drug chief Dr Patrizia Cavazzoni left the agency to serve as chief medical officer of Pfizer.

Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In this role, Dr Cavazzoni will lead ...

Without enough staff at the CDER, which receives user fees, the FDA could find itself in a position where it's not able to use access its fees, according to the lawmakers. “This would be ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of the ...

The former CDER leader will succeed Aida Habtezion, M.D., who served as Pfizer’s CMO and head of worldwide medical and safety for four years, and will be leaving the pharma to "pursue other ...